Why Now Is The Time To Buy The Cooper Companies: Analyst Highlights Optometry And Women's Health Growth
Portfolio Pulse from Nabaparna Bhattacharya
Mizuho analyst Anthony Petrone reiterated a Buy rating on The Cooper Companies, Inc. (NYSE:COO) with a price target of $440. The company is set to report quarterly results on August 30. Petrone sees current levels as an attractive entry point due to the company's potential to benefit from resurgent optometry and women's health volumes. The analyst's estimates for the quarter's revenue/EPS are $896.1 million/$3.34. COO's CooperSurgical (CSI) business represents ~one-third of overall COO revenue, and with the majority of CSI exposed to obstetrics, the analyst forecasts segment growth.
August 28, 2023 | 6:49 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mizuho analyst Anthony Petrone reiterated a Buy rating on The Cooper Companies, Inc. (NYSE:COO) with a price target of $440. The company is set to report quarterly results on August 30. The analyst's estimates for the quarter's revenue/EPS are $896.1 million/$3.34.
The analyst's Buy rating and the upcoming quarterly results announcement could potentially drive the stock price up. The analyst's positive outlook on the company's potential to benefit from resurgent optometry and women's health volumes also adds to the positive sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100